Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 9, 2002, Pages 3080-3083

  Balestrieri, Emanuela ^a   Forte, Giancarlo ^a   Matteucci, Claudia ^a   Mastino, Antonio ^a   Macchi, Beatrice ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; INHIBITION KINETICS; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; COCULTURE TECHNIQUES; DELTARETROVIRUS INFECTIONS; DNA, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LAMIVUDINE; MONOCYTES; VIRUS REPLICATION;

EID: 0036721171     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.9.3080-3083.2002     Document Type: Article

References (18)

1. YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro
2. Intrathecal synthesis of IgG antibodies to HTLV-1 supports an etiological role for HTLV-1 in tropical spastic paraparesis
3. (-)-2′-Deoxy-3′-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro
4. Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase
5. Susceptibility of human T cell leukemia virus type 1 to reverse transcriptase inhibitors: Evidence for resistance to lamivudine
6. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less
7. Clinical pharmacokinetics of lamivudine
8. Detection of the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction
9. Profound immunosuppression of hepatitis B virus replication with lamivudine
10. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro
11. In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs
12. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leucocytes and human leukemic cells
13. HTLV-1 associated myelopathy, a new clinical entity
14. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
15. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine and indinavir during primary human immunodeficiency virus type 1 infection
16. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-Tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy
17. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease
18. Efficacy of 3′-azido-3′-deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells